Regional manufacturing hub Meiji Pharma Spain operates two production plants in Alcalá de Henares and serves as a key export and production partner for Meiji Seika Pharma, presenting opportunities to discuss contract manufacturing, fill-finish, and private-label collaborations for regional or global distribution.

Growth through export With a global export orientation and production capabilities for internationally marketed products, there is potential to engage in distribution partnerships, co-branding, or licensing deals for the Spanish subsidiary to expand into new markets, including the Americas and Asia.

R&D and innovation An in-house research, development and innovation center signals readiness for collaborative development programs, technology transfers, or joint-innovation projects centered on advanced formulations, generics with value-added attributes, or biosimilars support.

Core product focus Producing a third-generation cephalosporin and an hyaluronic acid-based product positions the company to offer allied API supply, finished dosage forms, or specialty injectables to hospitals and multinational partners seeking dependable Spanish supply sources.

Recognition-driven partner Awarded Outstanding Performance for 2023 and recognized as a top subsidiary, Meiji Pharma Spain demonstrates reliability and quality credentials that can be leveraged in sales pitches to win new customers seeking established, compliant, and high-performing suppliers.